03/17/2026
In Behavioral Health M&A, 2026 will belong to the prepared.
While much of the industry conversation has focused on a post-pandemic "correction," the data tells a different story: 2025 has been Mertz Taggart’s busiest year for behavioral health transactions since the 2021 peak.
The market isn’t slowing down—it’s maturing. 📈
As we look toward 2026, private equity "platform" investments are signaling a significant wave of add-on acquisition activity. However, the bar for due diligence has never been higher.
To command a premium multiple in this environment, owners must look beyond top-line growth and prioritize three core pillars:
✅ EBITDA Normalization: Accurately identifying the true "pro-forma" value of the organization.
✅ Payer Diversification: De-risking revenue streams to protect valuation during diligence.
✅ Operational Scalability: Demonstrating a clinical and financial model that thrives across multiple locations.
Whether an exit is 6 months or 3 years away, the operational decisions made today will determine the eventual "walk-away" value at the closing table.
We published a comprehensive 2026 Behavioral Health Outlook to help founders prepare their clinical and financial operations for a successful transition.
Read the full briefing here: https://www.mertztaggart.com/post/how-to-prepare-your-behavioral-health-business-for-sale-in-2026
A practical guide for behavioral health business owners on valuation drivers, buyer expectations, and M&A trends shaping deals in 2026 and beyond.